Location: Champalimaud Centre for the Unknown, Lisbon
Employer: Champalimaud Foundation
Job Type: Full Time
Position: Postdoctoral Positions
Application Starts: 26 Jul. 2021

Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud (Champalimaud Foundation), a private, non-profit research institution, is opening a call for a Postdoctoral Researcher for Papanikolaou group.

Eligible candidates must hold a PhD or Doctorate degree and will be offered an employment contract with unknown term, within the scope of the research project entitled “ProCancer-i”; with the reference “952159” – from the call Nº H2020-SC1-FA-DTS-2019-1, funded by the European Union’s Horizon 2020 research and innovation programme.

The contract is to be entered into by and between the Champalimaud Foundation and the selected candidate in accordance with all applicable legislation, including Law-Decree 57/2016, of the 29 of August of 2016 in its current edition and the General Labour Code, as well as the internal rules and regulations of the Champalimaud Foundation, taking into account the conditions set out in the above mentioned Law-Decree for the recruitment of PhD Holders within the scope of research projects funded by public funds
Work Plan

Participate in the development of Deep Learning based models and Radiomics Signatures that will be extracted from mpMRI images from a total number of 17000 patients with prostate cancer, with a focus on statistical analysis concepts including but not limited to feature selection/reduction, ML modelling using survival analysis and other clinical outcomes.

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Twitter feed is not available at the moment.

Stay in touch!